ASCO Publications
5 days ago · Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and …
Updates on Systemic Therapy for Hepatocellular Carcinoma
Jan 4, 2024 · This review explores the dynamic landscape of hepatocellular carcinoma (HCC) treatment, emphasizing on recent developments across various stages and therapeutic …
Survival in Patients With Brain Metastases: Summary Report on the ...
Sep 15, 2020 · Significant prognostic factors varied by diagnosis and new prognostic factors were identified. Those factors were incorporated into the updated GPA with robust separation (P < …
Prevention and Management of Chemotherapy-Induced …
Jul 14, 2020 · The identified data reconfirmed that no agents are recommended for the prevention of CIPN. The use of acetyl-l-carnitine for the prevention of CIPN in patients with cancer should …
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Oct 17, 2022 · Colorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide. 1 Almost 150,000 new cases and more than 50,000 deaths from CRC are reported …
Journal of Clinical Oncology - ASCO Publications
Dec 16, 2024 · Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and …
Systemic Treatment of Patients With Metastatic Breast Cancer: …
Jan 10, 2024 · Clinicians should recommend treatment according to menopausal status, pathological and biomarker features when quality results are available. In first-line, for …
Palliative Care for Patients With Cancer: ASCO Guideline Update
May 15, 2024 · Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and …
Vaccination of Adults With Cancer: ASCO Guideline
Mar 18, 2024 · ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline …
Management of Immune-Related Adverse Events in Patients …
Immunotherapy has revolutionized the treatment of many different types of cancers. Immune checkpoint inhibitors (ICPis) targeting cytotoxic T-lymphocyte–associated antigen-4 (CTLA-4), …